Mr. Previn held the position of Managing Director from 2003 to 2005. In July of 2005, Mr. Previn was elected Chairman of the Ellex board of directors.
Victor Previn was appointed a director on 16 July 2001 after the acquisition of Ellex Laser Systems. Victor Previn is a professional engineer and one of the original founders of Ellex. His career spans more than 30 years in the laser industry. Mr. Previn was responsible for developing and commercialising the technology platform that is now the core of Ellex’s current production. He has spent more than 30 years in the ophthalmic laser industry travelling widely throughout Asia, Europe and the USA in a business development capacity.
Mr. Previn held the position of Managing Director from 2003 to 2005. In July of 2005, Mr. Previn was elected Chairman of the Ellex board of directors. He is also a member of the Audit & Risk Committee, Remuneration Committee and Nomination Committee.
Rahmon was appointed a Independent Director on 17 May 2013.
Rahmon Rahmon Coupe was appointed an Independent Director on 15 May 2013. Mr Coupe is Chief Executive Officer and Director of YourAmigo Limited, an organic search engine solutions company. Mr. Coupe has more than 30 years’ experience in the areas of corporate management, intellectual property management, contract negotiation, business development and engineering and has worked across a diverse range of industries, including information technology and the internet, life sciences and public broadcasting. Mr. Coupe has held various project and engineering management roles for government research-based organisations, including the Defence Science and Technology Organisation (DSTO). Mr. Coupe holds an Honours Degree in Electrical and Electronic Engineering from the University of Adelaide and was awarded the Ernst & Young Entrepreneur of the Year in Technology and Emerging Industries for the Central Region of Australia in 2009. He is currently a member of the Remuneration Committee.
Alex was appointed a Non-Executive Director on 22 July 2005.
Alex Sundich was appointed a non- executive director on 22 July 2005. Alex is currently an Executive Director of Bridge Street Capital Partners, a corporate advisory and principal investment firm. Prior to this, Alex was a senior executive in the funds management industry and an investment banker with Goldman Sachs and CSFB, involved in mergers and acquisitions and capital raisings. He is currently Chairman of the Audit & Risk Committee and Chairman of the Nomination Committee.
Alex holds a Bachelor of Economics from the University of Sydney and a Master of Commerce (Finance) from the University of New South Wales. Alex is a member of the Institute of Chartered Accountants in Australia and NZ, the Financial Services Institute of Australia and the Australian Institute of Company Directors. He is also the Chairman of Petrel Energy Limited.
Mike was appointed an Executive Director on 2 July 2018.
Mr Southard was appointed as an Executive Director on 2 July 2018. Mike Southard spent 25 years with the
world’s largest ophthalmology company, Alcon Laboratories of Fort Worth Texas, as Vice President of the Global Surgical business. During Mike’s tenure, the Alcon business grew dramatically from US$85 million to US$2.4 billion of sales per year. Prior to this, he was an executive with Beecham Laboratories (now SmithKline Beecham), and Cooper-Vision, which was acquired by Alcon Laboratories. Mike is currently actively involved in Ophthalmology, Dermatology and Orthopaedics through his consulting company based in Portland, Oregon, USA. He has vast experience in both the International and U.S. markets and maintains important contacts with many of the world’s key opinion leaders in all areas of eye surgery. Mike holds a Bachelor of Science Degree from Oregon State University, in Business, and also an executive MBA degree from Stanford University. Mike has served on Scientific Advisory Boards, Industry Advisory Councils, and also represented the International Markets and the Eye Surgery segment on the team that lead the initial public offering of Alcon in the early 2000’s.
Mike was appointed a Non-Executive Director on 2 July 2018.
Mr Mangano was appointed as an Independent Director on 2 July 2018.
Mike Mangano is an accomplished global executive leader with over 23 years’ experience in the medical device industry.
He was most recently the President and CEO of ReShape Medical Inc., a U.S. venture backed company focused on obesity that was sold in October of 2017. Prior to ReShape, he was President of the Americas for Sirtex Medical for over six years. At Sirtex Mike grew the business from US$30 million to over US$140 million of sales per year, while building a team of 17 to more than 130 employees. Prior to Sirtex, he spent 15 years with Boston Scientific in numerous senior executive roles, including two overseas positions in Japan and Australia. He has vast experience in sales and marketing management, product development, strategic planning, international business, M&A, project management, and business model development. He currently is a member of the board of directors of ABK Biomedical.